| Literature DB >> 34029068 |
Melanie T Odenkirk1, David M Reif2,3, Erin S Baker1.
Abstract
The need for holistic molecular measurements to better understand disease initiation, development, diagnosis, and therapy has led to an increasing number of multiomic analyses. The wealth of information available from multiomic assessments, however, requires both the evaluation and interpretation of extremely large data sets, limiting analysis throughput and ease of adoption. Computational methods utilizing artificial intelligence (AI) provide the most promising way to address these challenges, yet despite the conceptual benefits of AI and its successful application in singular omic studies, the widespread use of AI in multiomic studies remains limited. Here, we discuss present and future capabilities of AI techniques in multiomic studies while introducing analytical checks and balances to validate the computational conclusions.Entities:
Year: 2021 PMID: 34029068 DOI: 10.1021/acs.analchem.0c04850
Source DB: PubMed Journal: Anal Chem ISSN: 0003-2700 Impact factor: 6.986